Beijing Zhidemai Technology (300785.SZ) shareholder and director Liu Chao collectively reduced holdings by 1.6014 million shares.

The era of buying blindly with closed eyes is over! The strategy of the seven giants in US stocks of holding together has failed. Wall Street calls for buying separately in 2026.

TRANSTHERA-B (02617) announced clinical data of single-agent treatment with tigeroxitinib in patients with advanced cholangiocarcinoma at the 2026 American Clinical Oncology Society Gastrointestinal Tumor Symposium.

APAC RESOURCES (01104) Announces Profit Forecast - Expects Shareholders' Net Profit for the first half of the 25/26 fiscal year to be approximately HK$1.4 billion to HK$1.9 billion, turning from a loss to a profit year on year.